AstraZeneca said on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's PFE.N early-stage rare disease gene therapy portfolio for up to $1 billion, plus royalties on sales.
FILE PHOTO-Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photosaid on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's early-stage rare disease gene therapy portfolio for up to $1 billion, plus royalties on sales.
AstraZeneca bought Alexion in 2021. It focuses on rare diseases and plans to close the deal in the third quarter, the British drugmaker said. The deal will bring a number of novel adeno-associated virus capsids to Alexion and help build on Alexion and AstraZeneca's capabilities in genomic medicine, it said.
AAV capsids have been shown to be an effective mechanism for delivering therapeutic gene cargos for gene therapy and gene editing, the company said.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair lossNature Medicine explores the latest translational and clinical research news, with a newly approved JAK and TEC inhibitor for the autoimmune disease alopecia areata.
Les mer »
Mega Millions lottery jackpot nears $1 billion ahead of Friday drawingLottery players this week may benefit from a Mega Millions jackpot approaching $1 billion, one of the largest.
Les mer »
Extreme heat to affect largest area of the Lower 48 yet through FridayAn unrelenting heat wave that’s baked the southern United States for weeks is expanding and will cover the most territory of the summer between Wednesday and Friday, swelling into the Upper Midwest and Northeast.
Les mer »
Mega Millions lottery jackpot nears $1B ahead of Friday drawingThe Mega Millions lottery jackpot is approaching $1 billion ahead of Friday’s drawing.
Les mer »